๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Utility of porphyrins and light in the diagnosis and treatment of malignancy

โœ Scribed by Neville R. Pimstone


Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
381 KB
Volume
5
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Diagnosis and treatment of fungal infect
โœ F. Radaelli; A. Cortelezzi; L. Zocchi; D. Castagnone; L. Baldini; M. Colombi; R. ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 442 KB

A diagnosis of deep-seated mycosis was made in 54 patients with hematologic malignancies, severe neutropenia and fever, based on a set of clinical and laboratory criteria. Standardized antifungal treatment was started in 31 patients who seven days after onset of fever had not responded to antibiotic

Hematoporphyrin derivative and laser pho
โœ Shou-Zhong Song; Jun-Heng Li; Jin Zou; Ming-Yan Shu; Fu-Yun Zhao; Mao-Lin Jin; Z ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 369 KB

This paper reports the use of hematoporphyrin derivative (HpD) with laser activation in China for the diagnosis and treatment of various kinds of malignant neoplasms. Fluorescence observation for diagnosis was performed for 170 tumors. One hundred and fifty-one (88.8%) fluoresced visably upon excit

Primary malignant tumors of bone. Evalua
โœ Murray M. Copeland ๐Ÿ“‚ Article ๐Ÿ“… 1967 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 885 KB

The author's experience in the diagnosis and treatment of primary malignant bone tumors (700 cases) is reviewed, together with the experience of the staff a t T h e University of Texas M. D. Anderson Hospital and Tumor Institute, to evaluate various approaches to diagnosis and treatment, and to dete

Anthracyclines in the treatment of malig
โœ Joseph J. Turchi; Cynthia Villasis ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 602 KB

This article reports two cases and reviews the literature regarding chemotherapy using anthracyclines during pregnancy. Twenty-six additional cases using this class of agents to treat malignancy during pregnancy are summarized from 18 reports for a total of 28 pregnancies. Final outcome of pregnancy